SLU-PP-332

NL-SLU332

SLU-PP-332 | 5mg | Lyophilized Injectable Powder
For In Vitro Research Use Only — Not for Human or Veterinary Use

Description:

NL-SLU332 is a small-molecule compound investigated in vitro as a PPARδ/β agonist with potential applications in metabolic and performance research. Experimental models have explored its involvement in lipid metabolism, mitochondrial function, cellular energy pathways, and endurance-related signaling under controlled laboratory conditions.

This 5mg lyophilized powder format is designed for precise reconstitution and controlled use in structured laboratory protocols.

Specifications:

• Unit Size: 5mg (lyophilized powder, single vial)

• Compound Type: PPARδ/β agonist (investigational small molecule)

• Form: Sterile, freeze-dried powder (for reconstitution)

• Molecular Weight: Small-molecule structure (exact value varies by preparation)

• Storage: Store sealed in a cool, dry place (2°C–8°C). Protect from heat, light, and moisture

Application Context:

SLU-PP-332 is studied in vitro for its potential roles in:

• Mitochondrial biogenesis and cellular energy metabolism

• Fatty acid oxidation and endurance-related pathways

• Skeletal muscle performance and adaptation models

• Glucose regulation and metabolic signaling pathways

• PPARδ/β receptor-mediated cellular processes